We are pleased to announce that the Lenbach Equity Opportunities III Fund, advised by the DUBAG Group, has successfully completed the acquisition of ItalPresseGauss S.r.l. from Altor. Based in Italy, ItalPresseGauss is a well-established provider of advanced die-casting technologies, with a strong track record in high-pressure aluminum die-casting solutions, automated work cells, and tailored production systems for customers […]

Munich/Barcelona, Juli 31, 2025 – We’re proud to announce that LEO III Fund has successfully acquired PronoKal Group from Nestlé Health Science. With this acquisition, PronoKal will now operate as an independent company – ready to strengthen its leading position in the fast-growing ketogenic nutrition market. Backed by a strong foundation in science-based, medically supervised nutrition, the company […]

In July 2025, Maren Blindert joined the DUBAG team as an Investment Analyst. She graduated with a Bachelor of Science in International Business with a focus on Finance from Maastricht University and holds an International Master of Finance from Católica Lisbon School of Business & Economics. Maren started at DUBAG as an Intern before joining […]

We’re thrilled to welcome TOKAI ERFTCARBON GmbH to the LEO III Fund portfolio! This acquisition reflects DUBAG Group’s continued commitment to unlocking value in complex corporate carve-outs. With a strong heritage in graphite electrode production and a skilled team on the ground, Tokai Erftcarbon is ideally positioned for long-term growth and operational excellence. We look forward to […]

On June 20th 2024, Sven Lüdiger joined the DUBAG team as an Investment Analyst. Sven studied at the University of Münster and University of California Berkeley Haas School of Business and graduated with a Bachelor of Science in Business Administration and a Master of Science in Finance and Economics. He started at DUBAG as an […]